Literature DB >> 19049876

Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Rajasekharan Somasundaram1, Dorothee Herlyn.   

Abstract

Chemokines and chemokine receptors play an important role in immune homeostasis and surveillance. Altered or defective expression of chemokines and/or chemokine receptors could lead to a disease state including autoimmune disorder or cancer. Tumors from glioblastoma, melanoma, and neuroblastoma secrete high levels of chemokines that can promote tumor growth and progression or induce stromal cells present in the tumor microenvironment to produce cytokines or chemokines which, in turn, can regulate angiogenesis, tumor growth, and metastasis. On the other hand, chemokines secreted by tumor or stromal cells can also attract leukocytes such as dendritic cells, macrophages, neutrophils, and lymphocytes which may downmodulate tumor growth. New therapies that are aimed at limiting tumor growth and progression by attracting immune effector cells to the tumor site with chemokines may hold the key to the successful treatment of cancer, although this approach may be hampered by possible tumor growth-stimulating effects of chemokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049876      PMCID: PMC2806055          DOI: 10.1016/j.semcancer.2008.11.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  67 in total

1.  Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.

Authors:  M Nesbit; H Schaider; T H Miller; M Herlyn
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

Authors:  S A Rempel; S Dudas; S Ge; J A Gutiérrez
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

3.  The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma.

Authors:  H Haghnegahdar; J Du; D Wang; R M Strieter; M D Burdick; L B Nanney; N Cardwell; J Luan; R Shattuck-Brandt; A Richmond
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

4.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.

Authors:  H Torisu; M Ono; H Kiryu; M Furue; Y Ohmoto; J Nakayama; Y Nishioka; S Sone; M Kuwano
Journal:  Int J Cancer       Date:  2000-01-15       Impact factor: 7.396

5.  Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.

Authors:  M Kunz; A Toksoy; M Goebeler; E Engelhardt; E Bröcker; R Gillitzer
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

Review 6.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma.

Authors:  E Lázár-Molnár; H Hegyesi; S Tóth; A Falus
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

7.  Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.

Authors:  T Fushimi; A Kojima; M A Moore; R G Crystal
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 8.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

9.  Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.

Authors:  Justin T Jordan; Wei Sun; S Farzana Hussain; Guillermo DeAngulo; Sujit S Prabhu; Amy B Heimberger
Journal:  Cancer Immunol Immunother       Date:  2007-05-24       Impact factor: 6.968

10.  The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.

Authors:  Roland Meier; Annick Mühlethaler-Mottet; Marjorie Flahaut; Aurélie Coulon; Carlo Fusco; Fawzia Louache; Katya Auderset; Katia Balmas Bourloud; Estelle Daudigeos; Curzio Ruegg; Gilles Vassal; Nicole Gross; Jean-Marc Joseph
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

View more
  23 in total

Review 1.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

Review 2.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

Review 3.  The role of tumor microenvironment in melanoma therapy resistance.

Authors:  Rajasekharan Somasundaram; Meenhard Herlyn; Stephan N Wagner
Journal:  Melanoma Manag       Date:  2016-02-12

4.  Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

Authors:  Kimbell L Hetzler; Justin P Hardee; Melissa J Puppa; Aditi A Narsale; Shuichi Sato; J Mark Davis; James A Carson
Journal:  Biochim Biophys Acta       Date:  2014-12-30

5.  Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.

Authors:  Vegard Tjomsland; Anna Spångeus; Johanna Välilä; Per Sandström; Kurt Borch; Henrik Druid; Sture Falkmer; Ursula Falkmer; Davorka Messmer; Marie Larsson
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

6.  Macrophages in skin melanoma-the key element in melanomagenesis.

Authors:  Malgorzata Pieniazek; Rafal Matkowski; Piotr Donizy
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

7.  Inherited variation in immune genes and pathways and glioblastoma risk.

Authors:  Judith A Schwartzbaum; Yuanyuan Xiao; Yanhong Liu; Spyros Tsavachidis; Mitchel S Berger; Melissa L Bondy; Jeffrey S Chang; Susan M Chang; Paul A Decker; Bo Ding; Sarah J Hepworth; Richard S Houlston; Fay J Hosking; Robert B Jenkins; Matthew L Kosel; Lucie S McCoy; Patricia A McKinney; Kenneth Muir; Joe S Patoka; Michael Prados; Terri Rice; Lindsay B Robertson; Minouk J Schoemaker; Sanjay Shete; Anthony J Swerdlow; Joe L Wiemels; John K Wiencke; Ping Yang; Margaret R Wrensch
Journal:  Carcinogenesis       Date:  2010-07-28       Impact factor: 4.944

8.  A Computational Framework for Genome-wide Characterization of the Human Disease Landscape.

Authors:  Young-Suk Lee; Arjun Krishnan; Rose Oughtred; Jennifer Rust; Christie S Chang; Joseph Ryu; Vessela N Kristensen; Kara Dolinski; Chandra L Theesfeld; Olga G Troyanskaya
Journal:  Cell Syst       Date:  2019-01-23       Impact factor: 10.304

9.  IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

Authors:  Fabrizio Mattei; Giovanna Schiavoni; Paola Sestili; Francesca Spadaro; Alessandra Fragale; Antonella Sistigu; Valeria Lucarini; Massimo Spada; Massimo Sanchez; Stefania Scala; Angela Battistini; Filippo Belardelli; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

10.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.